SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : NASI (North American Scientific, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: richard houchin who wrote (503)4/6/1998 10:24:00 PM
From: THE BIG GB  Read Replies (1) | Respond to of 658
 
nasi can take care of it self. if there's fear about owning

this stock what do you think about those whom invested in

INIS. I will be invested in NASI for atleast five years.



To: richard houchin who wrote (503)4/21/1998 12:06:00 AM
From: TJL  Read Replies (1) | Respond to of 658
 
Sorry for the delay on the summary of the annual meeting on 4/3/98. Below are some highlights of the meeting.

- The company is currently ramping up production of its IoGold iodine seeds. They are ahead of plan. Plan was 10,000 seeds per week by April and 20,000 by December. Will do the ramp up rationally, do not want to run the risk of not doing it right.

- Currently adding equipment and will have to expand to new facilities by year end. They are currently looking for additional space.

- Core business was flat last quarter because of problems with their distributor. The problems have been corrected. They also hired a new director of mtk. Will eventuality faze out the core business and focus 100% on the brachytherapy business.

- They do not see supply keeping up with demand(seeding) for another 2 - 3 years. Will see significant increase in earnings from sales of the IoGold seeds. This is a direct quote from Irwin Gruverman(Chairman) " There will be some pleasant surprises ahead" when referring to the earnings in the future.

- They are hoping for Palladium approval from the FDA by mid-year. They will be producing the Palladium seed from the two linear accelerators acquired from PracSys's, licensed Nested High Voltage Generator Technology, by year end. The linear accelerators produce palladium by proton operation. If everything is successful and goes as planned, each accelerator can produce what 4 or 5 cyclotrons produce. They will be in the process of testing the acceleators within the next few months. Gruverman was very confident that they will be successful with the accelerators. They are also looking for other sources for palladium(back-up plan).

- They are looking for a CFO who has experience in acquisitions. They will explore that area.

- They are excited about the prospects with RadioMed, the commercialization of radioactive sources for the treatment of coronary artery restenosis. They do not see revenue from this venture for another 2 years.

- They stated there main goal is to be THE SUPPLIER OF CHOICE OF RADIOACTIVE MATERIALS.

The meeting was very positive. I was very impressed with management and there plans for the future. Ever since I came back from the meeting I've been buying more shares. I've been loading up on this recent pullback. At 33 this stock is a steal.

Richard please add to my comments if I left anything out. It was great meeting you and Herb.